Drilldown: Medicines
Appearance
Use the filters below to narrow your results.
generic:
mechanism:
5-HT2A agonist (26) ·
Potent 5-HT2A agonist (5) ·
LSD analogue; 5-HT2A agonist (4) ·
Prodrug of LSD; 5-HT2A agonist (4) ·
Monoamine releasing agent (3) ·
Serotonin releasing agent; 5-HT2A agonist (3) ·
Serotonin/norepinephrine/dopamine releasing agent (3) ·
Contains LSA (2) ·
Contains mescaline (2) ·
Serotonin releasing agent (2)
None (84) ·
Schizophrenia (FDA-approved 2015). Adjunctive treatment of major depressive disorder (2015). '''Agitation associated with dementia due to Alzheimer disease''' (FDA-approved May 2023, first agent specifically approved for this problem). Investigational for PTSD (combined with sertraline). (1)
Showing below up to 87 results in range #1 to #87.


